Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/2003
03/20/2003US20030055012 Prodrugs of COX-2 inhibitors
03/20/2003US20030055006 Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/tie receptor function and their use
03/20/2003US20030055003 Administering copper chelator and activated protein C (APC) or protein C or agent that increases the synthesis of protein C in the animal, or both, an activator of protein C for therapy
03/20/2003US20030054990 Methods of using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
03/20/2003US20030054974 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
03/20/2003US20030054452 Lysolipid for use in controlling apoptosis and treating inflammatory and innumological disorders
03/20/2003US20030054445 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01
03/20/2003US20030054409 Novel complex-forming proteins
03/20/2003US20030054046 Hydrated dressing containing metal microbiocide
03/20/2003US20030054037 Pharmaceutical compositions of adsorbates of amorphous drug
03/20/2003US20030054034 Water soluble film forming polymer and microbiocide oil
03/20/2003US20030053984 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins
03/20/2003US20030053958 For treating pulmonary hypertension; sustained release; has no effect on heart rate
03/20/2003CA2472102A1 Calcium-influx inhibitory factor and method of isolation thereof
03/20/2003CA2460348A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
03/20/2003CA2459890A1 Crystal structure of baff, and use thereof in drug design
03/20/2003CA2459882A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors
03/20/2003CA2459515A1 Indole derivatives
03/20/2003CA2459464A1 Tetrahydropyran derivatives and their use as therapeutic agents
03/20/2003CA2459445A1 Benzothiepine ileal bile acid transport inhibitors
03/20/2003CA2457092A1 Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy
03/19/2003EP1293566A1 A soluble toll-like receptor
03/19/2003EP1293506A1 New 1-(1-(Hetero)aryl-1-perhydroxyalkylmethyl)-Piperazine derivatives, process for their preparation and pharmaceutical compositions containing the same
03/19/2003EP1293497A1 Process for the production of calcium pantothenate
03/19/2003EP1293214A2 LTB4 antagonists and radiopharmaceuticals for imaging infection and inflammation
03/19/2003EP1293201A2 Use of aminoadamantane compounds as immunoregulators
03/19/2003EP1292685A2 Human lyases
03/19/2003EP1292684A2 Proteases
03/19/2003EP1292683A2 Secreted redox proteins
03/19/2003EP1292678A2 G-protein coupled receptors
03/19/2003EP1292619A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
03/19/2003EP1292608A2 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses
03/19/2003EP1292604A1 2-aminocarbonyl-9h-purine derivatives
03/19/2003EP1292596A1 1,3,8-triaza-spiro[4,5]decan-4-one derivatives as neurokinin receptor antagonists
03/19/2003EP1292590A1 Admantane derivatives
03/19/2003EP1292576A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
03/19/2003EP1292324A2 Critical illness neuropathy
03/19/2003EP1292322A1 Immunosuppressor agent derived from morbillivirus
03/19/2003EP1292314A2 Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of glycosaminoglycans
03/19/2003EP1292307A2 Method of treating pain using nalbuphine and opioid antagonists
03/19/2003EP1292296A1 Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect
03/19/2003EP1292286A1 Dry-powder pharmaceutical formulation for inhalation comprising alpha4-integrin antagonist
03/19/2003EP1292284A2 Encapsulation of polynucleotides and drugs into targeted liposomes
03/19/2003EP1292279A1 The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
03/19/2003EP1278528A4 Nucleoside analogs with carboxamidine-modified bicyclic base
03/19/2003EP1257281A4 Nucleoside analogs with carboxamidine modified monocyclic base
03/19/2003EP1178984B1 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
03/19/2003EP1102579B1 Medicinal aerosol formulations
03/19/2003EP1100470B1 Fast dissolving ibuprofen containing compositions having analgesic activity
03/19/2003EP0952853B1 Conjugate comprising an active agent, a polypeptide and a polyether
03/19/2003EP0944636B1 PHENYL GLYOXAMIDES AS sPLA2 INHIBITORS
03/19/2003EP0934312B1 1,4-disubstituted piperazines
03/19/2003EP0900203B1 Quinoline derivatives, processes for their preparation, and their use as medicaments
03/19/2003EP0876482B1 Il-13 receptor polypeptide
03/19/2003EP0745094B1 Superagonists and antagonists of human il-6, and method for their selection
03/19/2003EP0677104B1 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use
03/19/2003EP0463101B2 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
03/19/2003CN1404487A High purity lipopeptides, lipopeptide micelles, process for preparing same
03/19/2003CN1404483A New AZa-indolyl derivatives
03/19/2003CN1404482A Pteridine compounds for the treatment of psoriasis
03/19/2003CN1404481A Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
03/19/2003CN1404480A Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes
03/19/2003CN1404479A Novel 1,3-dihydro-2H-indol-2-one derivatives their preparing method and the pharmceutical composition containing the same
03/19/2003CN1404477A 哌嗪和哌啶衍生物 Piperazine and piperidine derivatives
03/19/2003CN1404468A Novel use of phenylheteroalkylamine derivatives
03/19/2003CN1404467A Aminosulfonylbiphenyl derivatives
03/19/2003CN1404400A Use of IL-18 inhibitors
03/19/2003CN1404391A Treating allergic and inflammatory conditions
03/19/2003CN1404390A TNF-alpha inhibitors
03/19/2003CN1404387A Cosmetic preparations containing plant extracts
03/19/2003CN1403454A N-substituted nitrogen heterocyclic compound
03/19/2003CN1403450A Prepn process and medicine composition of andrographolide derivatives
03/19/2003CN1403445A N-substituted nitrogen heterocyclic compound
03/19/2003CN1403159A Application of matrix metalloprotease tissue inhibitor in preparing medicine for preventing and treating arthritis
03/19/2003CN1403107A Pain-stopping bone-penetrating ointment and its prepn
03/19/2003CN1403103A Arthralgia pain treating bolus and its prepn
03/19/2003CN1403095A Stress stimulant injection and its recipe and production process
03/19/2003CN1403086A Coculine-phosphatide composite and its prepn
03/19/2003CN1103219C Formulations containing hyaluronic acid
03/18/2003US6534544 Methods of treatment with compounds having RARα receptor specific or selective activity
03/18/2003US6534542 For alleviating chronic pain and allodynia and have no or only minimal cardivascular and/or sedatory activity
03/18/2003US6534521 Useful in the treatment of inflammation, atherosclerosis, restenosis, and immune disorders such as arthritis and transplant rejection
03/18/2003US6534518 Polysubstituted 6-phenylphenanthridines with PDE-IV inhibiting activity
03/18/2003US6534509 Derivatives are useful as anti-inflammatory agents. This invention is also directed to pharmacetutical compostions for inflammation
03/18/2003US6534498 Protease inhibitors
03/18/2003US6534486 With broad anti-inflammatory properties which inhibit leukocyte recruitment and activation and which are agonists of the adenosine 2a receptor are described.
03/18/2003US6534483 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
03/18/2003US6534478 Cyclic azapeptides with angiogenic effect
03/18/2003US6534476 Smad6 and uses thereof
03/18/2003US6534275 Isolated polypeptide having specified amino acid sequence or immunogenic fragment thereof
03/18/2003US6534261 Regulation of endogenous gene expression in cells using zinc finger proteins
03/18/2003US6534061 Isolated DNA98853 and DNA101848 polypeptides
03/18/2003CA2269994C 7-hetero-bicyclo¬2.2.1|-heptanes
03/18/2003CA2162708C Bicyclic amide derivatives and their use as muscle relaxants
03/18/2003CA2141048C Substituted benzylamino nitrogen containing non-aromatic heterocycles
03/18/2003CA1341425C Antibodies to angiogenin: immunotherapeutic agents
03/17/2003CA2403058A1 Dna encoding the chimpanzee prostaglandin e2 receptor ep4 subtype
03/14/2003WO2002026710A1 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis
03/14/2003CA2422613A1 5-phenylbenzylamine compound, process for preparing the same and synthetic intermediate thereof
03/13/2003WO2003021262A1 Screening method
1 ... 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 ... 1272